Department of Trauma and Critical Care, Rinku General Medical Centre, Senshu Trauma and Critical Care Centre, 2-23 Rinku Orai-kita, Izumisano, Osaka, 598-8577, Japan.
Division of Trauma and Surgical Critical Care, Osaka General Medical Centre, 3-1-56 Bandai-Higashi, Sumiyoshi-ku, Osaka, 558-8558, Japan.
Scand J Trauma Resusc Emerg Med. 2019 Feb 28;27(1):25. doi: 10.1186/s13049-019-0606-6.
Acute coagulopathy is a well-known predictor of poor outcomes in patients with severe trauma. However, using coagulation and fibrinolytic markers, how one can best predict mortality to find out potential candidates for treatment of coagulopathy remains unclear. This study aimed to determine preferential markers and their optimal cut-off values for mortality prediction.
We conducted a retrospective observational study of patients with severe blunt trauma (injury severity score ≥ 16) transferred directly from the scene to emergency departments at two trauma centres in Japan from January 2013 to December 2015. We investigated the impact and optimal cut-off values of initial coagulation (platelet counts, fibrinogen and prothrombin time-international normalised ratio) and a fibrinolytic marker (D-dimer) on 28-day mortality via classification and regression tree (CART) analysis. Multivariate logistic regression analysis confirmed the importance of these markers. Receiver operating characteristic curve analyses were used to examine the prediction accuracy for mortality.
Totally 666 patients with severe blunt trauma were analysed. CART analysis revealed that the initial discriminator was fibrinogen (cut-off, 130 mg/dL) and the second discriminator was D-dimer (cut-off, 110 μg/mL in the lower fibrinogen subgroup; 118 μg/mL in the higher fibrinogen subgroup). The 28-day mortality was 90.0% (lower fibrinogen, higher D-dimer), 27.8% (lower fibrinogen, lower D-dimer), 27.7% (higher fibrinogen, higher D-dimer) and 3.4% (higher fibrinogen, lower D-dimer). Multivariate logistic regression demonstrated that fibrinogen levels < 130 mg/dL (adjusted odds ratio [aOR], 9.55; 95% confidence interval [CI], 4.50-22.60) and D-dimer ≥110 μg/mL (aOR, 5.89; 95% CI, 2.78-12.70) were independently associated with 28-day mortality after adjusting for probability of survival by the trauma and injury severity score (TRISS Ps). Compared with the TRISS Ps alone (0.900; 95% CI, 0.870-0.931), TRISS Ps with fibrinogen and D-dimer yielded a significantly higher area under the curve (0.942; 95% CI, 0.920-0.964; p < 0.001).
Fibrinogen and D-dimer were the principal markers for stratification of mortality in patients with severe blunt trauma. These markers could function as therapeutic targets because they were significant predictors of mortality, independent from severity of injury.
急性凝血功能障碍是严重创伤患者预后不良的一个众所周知的预测因素。然而,使用凝血和纤维蛋白溶解标志物,如何最好地预测死亡率以确定潜在的凝血功能障碍治疗候选者仍然不清楚。本研究旨在确定用于预测死亡率的首选标志物及其最佳截断值。
我们对 2013 年 1 月至 2015 年 12 月期间直接从现场转运至日本两家创伤中心的严重钝器伤(损伤严重程度评分≥16)患者进行了回顾性观察性研究。我们通过分类回归树(CART)分析,研究了初始凝血(血小板计数、纤维蛋白原和凝血酶原时间国际标准化比值)和纤维蛋白溶解标志物(D-二聚体)对 28 天死亡率的影响和最佳截断值。多变量逻辑回归分析证实了这些标志物的重要性。使用受试者工作特征曲线分析评估死亡率的预测准确性。
共分析了 666 例严重钝器伤患者。CART 分析显示,初始判别器为纤维蛋白原(截断值为 130mg/dL),第二个判别器为 D-二聚体(在较低纤维蛋白原亚组中截断值为 110μg/mL;在较高纤维蛋白原亚组中截断值为 118μg/mL)。28 天死亡率为 90.0%(低纤维蛋白原,高 D-二聚体)、27.8%(低纤维蛋白原,低 D-二聚体)、27.7%(高纤维蛋白原,高 D-二聚体)和 3.4%(高纤维蛋白原,低 D-二聚体)。多变量逻辑回归表明,纤维蛋白原水平<130mg/dL(调整后的优势比[aOR],9.55;95%置信区间[CI],4.50-22.60)和 D-二聚体≥110μg/mL(aOR,5.89;95%CI,2.78-12.70)与调整创伤和损伤严重程度评分(TRISS Ps)后的 28 天死亡率独立相关。与单独的 TRISS Ps(0.900;95%CI,0.870-0.931)相比,TRISS Ps 结合纤维蛋白原和 D-二聚体显著提高了曲线下面积(0.942;95%CI,0.920-0.964;p<0.001)。
纤维蛋白原和 D-二聚体是严重钝器伤患者分层死亡率的主要标志物。这些标志物可以作为治疗靶点,因为它们是死亡率的显著预测因素,与损伤严重程度无关。